 |
|
|
| |
Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data From Clinical Trials
|
| |
| |
Reported by Jules Levin
IDWeek 2017; October 4-8, 2017; San Diego, CA
Cassandra Nan,1Mark Shaefer,2Rimgaile Urbaityte,3James Oyee,3Judy Hopking,3Leigh Ragone,2Cynthia McCoig,4Vani Vannappagari2
1GlaxoSmithKline, Stevenage, UK; 2ViiV Healthcare, Research Triangle Park, NC; 3GlaxoSmithKline, Stockley Park, UK; 4ViiV Healthcare, Madrid, Spain
|
| |
|
|
|
|
|
